MM
Mike Mensinger
Chief Product Officer

Mike Mensinger insider trades: Beta Bionics (BBNX) stock buys and sales

Chief Product Officer, Beta Bionics Last trade Oct 27, 2026 13 Form 4 filings
$597K
Sold, last 12 months
8 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mike reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 27, 2026BBNX↓ Sell$58K
Sep 16, 2026BBNX↓ Sell$58K
Sep 2, 2026BBNX↓ Sell$84K
Jun 2, 2026BBNX↓ Sell$55K
Mar 2, 2026BBNX↓ Sell$13K
Jan 6, 2026BBNX↓ Sell$66K
Jan 2, 2026BBNX↓ Sell$231K
Dec 2, 2025BBNX↓ Sell$31K
Sep 2, 2025BBNX↓ Sell$21K
Jun 2, 2025BBNX↓ Sell$20K
Jan 31, 2025BBNX↑ Buy$567K
Jan 31, 2025BBNX↓ Sell$221

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BBNX insiders

Open-market trades in the last 12 months

About Mike Mensinger's insider trades

Mike Mensinger is Chief Product Officer at Beta Bionics (BBNX). Since Jan 31, 2025, Mike has reported 1 open-market purchase worth $567K and 11 sales worth $638K on SEC Form 4. In the last 12 months: 8 sales ($597K).

Their filings also include grants and awards (4 filings), conversions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BBNX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.